Bristol Myers Squibb is dedicated to R&D – with nearly 75 currently recruiting trials across areas including cancer, liver fibrosis, autoimmune diseases, heart failure and more, we know first-hand the importance of clinical trials in the development of innovative therapies.

However, despite the fact that clinical trial results may have potential benefits for future patients, several barriers to clinical trial participation still remain.

While there are a large number of trials enrolling at any given time, trials addressing a specific condition or located in a certain geographic area can often be difficult for patients to find. A recent survey from Memorial Sloan Kettering Cancer Center found that up to 63 percent of patients who do not qualify for a particular clinical trial do not search for another study that they may be more appropriate for.

Trial enrollment isn’t only difficult for patients. In fact, nearly 30 percent of all time spent on clinical trials by site staff is used recruiting and enrolling patients, and timelines for late-stage studies usually end up doubling in length, in order to meet desired enrollment levels.

Despite this, nearly half (48 percent) of all trial sites never reach full enrollment, and 11 percent of clinical trials never enroll a single patient. 

Introducing an updated clinical trial resource